Aberrant glucose metabolism drives dysfunction of CD4 T cells in systemic lupus erythematosus and disease flares.

INTRODUCTION

T cell immuno-metabolic regulation plays a key role in the development of systemic lupus erythematosus (SLE). This study aimed to analyze the role of CD4 T cell glucose metabolism in SLE development.

MATERIAL AND METHODS

Clinical data and blood samples were collected from 20 untreated SLE patients and healthy controls (HCs) matched for age, sex, and body mass index. After being isolated by magnetic sorting and cultured with anti-CD3/CD28 for 72 h, CD4 T cells were subjected to real-time metabolic analysis. CD4 T cell proliferation and cytokines were measured with cell counting kit-8 and Luminex liquid chip assay, respectively.

RESULTS

Compared to HCs, SLE-CD4 T cells exhibited significantly higher glycolytic capacity and mitochondrial oxidative phosphorylation (OXPHOS) (both p < 0.001). Additionally, SLE-CD4 T cells demonstrated increased proliferation rates and elevated cytokine levels in both plasma and culture supernatants (both p < 0.05). OXPHOS and glycolysis of SLE-CD4 T cells were positively correlated with SLE disease activity index-2000 (SLEDAI-2K) and cytokines, and negatively correlated with SLE-CD4 T cell numbers (all p < 0.05).

CONCLUSIONS

CD4 T cells from SLE patients showed higher glucose metabolic activity than those from HCs, and the enhanced glucose metabolism of SLE-CD4 T cells was strongly correlated with disease activity, suggesting that glucose metabolic reprogramming plays an essential role in the pathogenesis of SLE.